Enzymatica publ AB

ST:ENZY Sweden Drug Manufacturers - Specialty & Generic
Market Cap
$47.60 Million
Skr534.02 Million SEK
Market Cap Rank
#25281 Global
#318 in Sweden
Share Price
Skr2.20
Change (1 day)
-3.51%
52-Week Range
Skr1.65 - Skr4.84
All Time High
Skr770.83
About

Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.

Enzymatica publ AB (ENZY) - Total Liabilities

Latest total liabilities as of September 2025: Skr13.56 Million SEK

Based on the latest financial reports, Enzymatica publ AB (ENZY) has total liabilities worth Skr13.56 Million SEK as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Enzymatica publ AB - Total Liabilities Trend (2007–2024)

This chart illustrates how Enzymatica publ AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Enzymatica publ AB Competitors by Total Liabilities

The table below lists competitors of Enzymatica publ AB ranked by their total liabilities.

Company Country Total Liabilities
Enogia SAS
PA:ALENO
France €13.68 Million
Munjal Auto Industries Limited
NSE:MUNJALAU
India ₹8.52 Billion
Kindly MD, Inc. Common Stock
NASDAQ:KDLY
USA $923.39K
Uni Charm Indonesia PT
JK:UCID
Indonesia Rp2.75 Trillion
Guyoung Technology Co. Ltd
KQ:053270
Korea ₩334.98 Billion
PJ Electronics Co. Ltd
KQ:006140
Korea ₩58.36 Billion
Chengdu PUTIAN Telecommunications Cable Company Limited
F:CUEH
Germany €160.02 Million

Liability Composition Analysis (2007–2024)

This chart breaks down Enzymatica publ AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 2.47 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.10 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.09 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Enzymatica publ AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Enzymatica publ AB (2007–2024)

The table below shows the annual total liabilities of Enzymatica publ AB from 2007 to 2024.

Year Total Liabilities Change
2024-12-31 Skr18.86 Million -61.76%
2023-12-31 Skr49.30 Million +2.46%
2022-12-31 Skr48.12 Million +50.06%
2021-12-31 Skr32.07 Million -42.09%
2020-12-31 Skr55.38 Million +94.26%
2019-12-31 Skr28.51 Million +11.74%
2018-12-31 Skr25.51 Million +10.33%
2017-12-31 Skr23.12 Million +12.26%
2016-12-31 Skr20.60 Million -5.80%
2015-12-31 Skr21.87 Million +124.44%
2014-12-31 Skr9.74 Million -5.32%
2013-12-31 Skr10.29 Million +424.20%
2012-12-31 Skr1.96 Million +47.59%
2011-12-31 Skr1.33 Million -55.47%
2010-12-31 Skr2.99 Million +40.67%
2009-12-31 Skr2.12 Million +21.62%
2008-12-31 Skr1.75 Million +87.94%
2007-12-31 Skr929.00K --